Estados Unidos · Plataformas y datos · Yahoo Finance

Stoke Therapeutics Inc (STOK) Q3 2026 Earnings Call Highlights: Strong Cash Runway and Phase 3 ...

Publicado por Yahoo Finance · Estados Unidos hace 8 h

Stoke Therapeutics Inc (STOK) ended Q3 2026 with $358.8 million in cash to fund operations into early 2028, while advancing its Phase 3 EMPEROR study toward top-line data expected…

Leer el artículo completo en Yahoo Finance Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (finance.yahoo.com)

Stoke Therapeutics Inc (STOK) Q3 2026 Earnings Call Highlights: Strong Cash Runway and Phase 3 ...

También te puede interesar

Sampo PLC (OTCMKTS:SAXPY) Stock Short Interest Declines 48.8%

Golden Dome Is a $185 Billion Program, but Anduril Is Private. Here Are the 3 Public Companies Building It.

Best Tech Stocks Right Now

Talking Costco: Why a special dividend might not be the right play

Grand Theft Callout: ‘GTA 6’ fans are missing work on the game’s release day because they ‘don’t want to wait’ anymore

Jaguar’s Bold EV Gamble Could Become the Auto Industry’s Survival Strategy

Stoke Therapeutics Inc (STOK) Q3 2026 Earnings Call Highlights: Strong Cash Runway and Phase 3 ...

Compartir

También te puede interesar

Sampo PLC (OTCMKTS:SAXPY) Stock Short Interest Declines 48.8%

Golden Dome Is a $185 Billion Program, but Anduril Is Private. Here Are the 3 Public Companies Building It.

Best Tech Stocks Right Now

Talking Costco: Why a special dividend might not be the right play

Grand Theft Callout: ‘GTA 6’ fans are missing work on the game’s release day because they ‘don’t want to wait’ anymore

Jaguar’s Bold EV Gamble Could Become the Auto Industry’s Survival Strategy